CAMPBELL VICTOR L 4

Accession 0001209191-19-009135

CIK 0000860730other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 7:37 PM ET

Size

35.9 KB

Accession

0001209191-19-009135

Form 4

Period: 2019-02-07

SVP

Transactions

Exercise/Conversion
Common Stock
2019-02-07$47.97/sh+41,625$1,996,751→ 231,493 total
Exercise/Conversion
Common Stock
2019-02-07$69.58/sh+10,245$712,847→ 256,738 total
Sale
Common Stock
2019-02-11$138.97/sh−28,084$3,902,949→ 189,868 total
Exercise/Conversion
Stock Appreciation Right
2019-02-07−19,125→ 0 total
Exercise: $47.97Exp: 2024-02-05→ Common Stock (19,125 underlying)
Exercise/Conversion
Stock Appreciation Right
2019-02-07−15,000→ 0 total
Exercise: $68.96Exp: 2025-02-04→ Common Stock (15,000 underlying)
Exercise/Conversion
Stock Appreciation Right
2019-02-07−7,340→ 7,340 total
Exercise: $81.96Exp: 2027-02-01→ Common Stock (7,340 underlying)
Exercise/Conversion
Stock Appreciation Right
2019-02-07−4,575→ 13,725 total
Exercise: $101.16Exp: 2028-01-31→ Common Stock (4,575 underlying)
Exercise/Conversion
Common Stock
2019-02-07$68.96/sh+15,000$1,034,400→ 246,493 total
Exercise/Conversion
Common Stock
2019-02-07$101.16/sh+4,575$462,807→ 268,653 total
Exercise/Conversion
Common Stock
2019-02-07$81.96/sh+7,340$601,586→ 264,078 total
Tax Payment
Common Stock
2019-02-07$140.62/sh−50,701$7,129,575→ 217,952 total
Exercise/Conversion
Stock Appreciation Right
2019-02-07−22,500→ 0 total
Exercise: $47.97Exp: 2024-02-05→ Common Stock (22,500 underlying)
Exercise/Conversion
Stock Appreciation Right
2019-02-07−10,245→ 3,415 total
Exercise: $69.58Exp: 2026-01-29→ Common Stock (10,245 underlying)

Holdings

Footnotes (7)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.74 to $139.13, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F2]The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.
[F3]The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.
[F4]The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.
[F5]The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017.
[F6]The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018.
[F7]The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019.

Documents

2 files

HCA Healthcare, Inc.

CIK 0000860730

Entity typeother